Specific Cytogenetic Abnormalities at Diagnosis Predict Survival after Hematopoietic Cell Transplant in Poor-Risk Pediatric Acute Myeloid Leukemia: A PDWP/EBMT Study

MLA

Sharma, Akshay, et al. “Specific Cytogenetic Abnormalities at Diagnosis Predict Survival after Hematopoietic Cell Transplant in Poor-Risk Pediatric Acute Myeloid Leukemia: A PDWP/EBMT Study.” Blood, vol. 140, no. 1, Number 1 Supplement 1, Nov. 2022, pp. 1882–84. EBSCOhost, https://doi.org/10.1182/blood-2022-162596.

APA

Sharma, A., Galimard, J.-E., Pryce, A., Bhoopalan, S., Dalissier, A., Dalle, J.-H., Locatelli, F., Jubert, C., Mirci-Danicar, O., Kitra-Roussou, V., Bertrand, Y., Fagioli, F., Rialland, F., Biffi, A., Wynn, R. F., Michel, G., Tambaro, F. P. P., Ahmari, A. A., Tbakhi, A., … Corbacioglu, S. (2022). Specific Cytogenetic Abnormalities at Diagnosis Predict Survival after Hematopoietic Cell Transplant in Poor-Risk Pediatric Acute Myeloid Leukemia: A PDWP/EBMT Study. Blood, 140(1, Number 1 Supplement 1), 1882–1884. https://doi.org/10.1182/blood-2022-162596

Chicago

Sharma, Akshay, Jacques-Emmanuel Galimard, Angharad Pryce, Senthil Bhoopalan, Arnaud Dalissier, Jean-Hugues Dalle, Franco Locatelli, et al. 2022. “Specific Cytogenetic Abnormalities at Diagnosis Predict Survival after Hematopoietic Cell Transplant in Poor-Risk Pediatric Acute Myeloid Leukemia: A PDWP/EBMT Study.” Blood 140 (1, Number 1 Supplement 1): 1882–84. doi:10.1182/blood-2022-162596.